NCT00952432

Brief Summary

The goal of the study is to utilize BCTQ(Boston Carpal Tunnel Questionnaire), VAS (Visual Analog Scale), NCS (Nerve Conduction Study), and MET(Multiple Excitability Test) to evaluate and compare the efficacy of Acupuncture Therapy and Carbamazepine in Patients with Carpal Tunnel Syndrome.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2009

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2009

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 3, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 6, 2009

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2011

Completed
Last Updated

April 12, 2011

Status Verified

April 1, 2011

Enrollment Period

2 years

First QC Date

August 3, 2009

Last Update Submit

April 11, 2011

Conditions

Keywords

Carpal Tunnel SyndromeMultiple Excitability TestNerve Conduction StudyQtracWcarbamazepineAcupuncture

Outcome Measures

Primary Outcomes (1)

  • Use QtracW and NCS to evaluate the changes between pre-treatment and post-treatment in patients in both arms.

    12 weeks

Secondary Outcomes (4)

  • use BCTQ to evaluate the efficacy of 2 arms at week 4 and at week 12.

    12 weeks

  • use VAS to evaluate the efficacy of 2 arms at week 5, 8 and 12.

    12 weeks

  • Use Quality of Life questionnaire to compare the efficacy of 2 arms at week 12.

    12 weeks

  • Evaluate the safety of 2 arms during the study period

    12 weeks

Study Arms (2)

ACUPUNCTURE

ACTIVE COMPARATOR

ACUPUNCTURE

Procedure: Acupuncture

MEDICATION

ACTIVE COMPARATOR

Carbamazepine

Drug: Carbamazepine

Interventions

Carbamazepine 200mg, 1/2 tablet, TID for 1 month

MEDICATION
AcupuncturePROCEDURE

Acupuncture

ACUPUNCTURE

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age greater than 20 years old
  • outpatient or inpatient subject with numbness of arm, clinically met diagnostic criteria of AAEM(American association of Electrodiagnostic Medicine CTS task force), and proven to have distal motor neurological disorder through nerve Conduction Study (distal motor latency \>4.6 msec, decreased SNAP \< 12uV or prolonged median sensory distal latency (palm to wrist) \> 2.5msec)。
  • Willing to sign the Informed Consent form

You may not qualify if:

  • subject with external hand injury or disformation
  • subject with Polyneuritis or Cervical nerve root lesions
  • Subject with peripheral hypertrophy, hypothyroidism, multiple myeloma, or amyloidosis
  • Allergic to Carbamazepine or similar type of medicine
  • inability to act independently, or in the opinion of the investigator, not suitable for the study
  • In the opinion of the investigator, the subject requires surgical repair of the Carpal Tunnel Syndrome, or the symptoms will be worsen result in irreversible damage to the subject if not treated with surgical repair within 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Medical University - Wan Fang Hospital

Taipei, Taiwan, 116, Taiwan

RECRUITING

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Interventions

CarbamazepineAcupuncture Therapy

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Intervention Hierarchy (Ancestors)

DibenzazepinesHeterocyclic Compounds, 3-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsComplementary TherapiesTherapeutics

Study Officials

  • Jia-Ying Sung, MD

    Taipei Medical University-Wan Fang Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jia-Ying Sung, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 3, 2009

First Posted

August 6, 2009

Study Start

May 1, 2009

Primary Completion

May 1, 2011

Study Completion

May 1, 2011

Last Updated

April 12, 2011

Record last verified: 2011-04

Locations